Improved health-related quality of life in patients with recurrent <i>Clostridioides difficile</i> infection after treatment with faecal microbiota transplantation
Since FMT cures, reduces the risk of new recurrences of CDI and improves the HRQoL of the patients, it should be offered as a treatment for patients with rCDI. Also, SHS is a useful and reliable instrument for measuring HRQoL in patients with rCDI.
Authors
- Henrik Hjortswang
- Åse Östholm Balkhed (ORCID: https://orcid.org/0000-0002-8250-8785)
- Lena Serrander (ORCID: https://orcid.org/0000-0002-9058-3582)
- Cecilia Magnusson (ORCID: https://orcid.org/0000-0002-5540-8930)
- Elis Ölfvingsson
Institutions
- Linköping University (SE)
- Region Jönköpings län (SE)
- Linköping University Hospital (SE)
Publication Details
- Journal
- Infectious Diseases
- Published
- 2024-10-26
- DOI
- https://doi.org/10.1080/23744235.2024.2415694
- Primary Topic
- Clostridium difficile and Clostridium perfringens research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Forskningsrådet i Sydöstra Sverige
- Medical Research Council